PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $709,000 | -0.6% | 11,851 | 0.0% | 0.01% | -10.0% |
| Q3 2020 | $713,000 | -79.6% | 11,851 | -82.2% | 0.01% | -79.6% |
| Q2 2020 | $3,496,000 | +44.6% | 66,613 | -7.6% | 0.05% | +28.9% |
| Q1 2020 | $2,418,000 | -22.3% | 72,113 | +5.7% | 0.04% | +22.6% |
| Q4 2019 | $3,110,000 | +18.0% | 68,213 | -1.4% | 0.03% | +6.9% |
| Q3 2019 | $2,635,000 | -12.5% | 69,213 | 0.0% | 0.03% | -9.4% |
| Q2 2019 | $3,011,000 | +19.9% | 69,213 | +4.9% | 0.03% | +14.3% |
| Q1 2019 | $2,511,000 | +35771.4% | 65,963 | +43584.1% | 0.03% | – |
| Q4 2018 | $7,000 | -95.4% | 151 | -95.4% | 0.00% | -100.0% |
| Q4 2017 | $151,000 | +21.8% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $124,000 | -21.0% | 3,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $157,000 | +15600.0% | 3,300 | +82400.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
| GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
| Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
| Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
| AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
| ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
| RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
| Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
| Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
| Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |